Meta-analysis of mycophenolate mofetil in IgA nephropathy

Nephrology

Volumn 13, Issue 1, 2008, Pages 90-

  Navaneethan, Sankar D ^a   Viswanathan, Gautham ^b   Strippoli, Giovanni F M ^c  

^a UNIVERSITY OF ROCHESTER   (United States)

^b St Catherine Hospital East Chicago   (United States)

^c Mario Negri Sud Consortium ^*  (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; STEROID;

CLINICAL TRIAL; CREATININE CLEARANCE; DIARRHEA; DISEASE COURSE; DRUG EFFICACY; GASTRITIS; HUMAN; IMMUNOGLOBULIN A NEPHROPATHY; INCIDENCE; KIDNEY FAILURE; KIDNEY FUNCTION; KIDNEY PRESERVATION; LETTER; LUPUS ERYTHEMATOSUS NEPHRITIS; MEDICAL LITERATURE; MEDICAL RESEARCH; MEMBRANOUS GLOMERULONEPHRITIS; META ANALYSIS; PRIORITY JOURNAL; PROTEINURIA; RENAL REPLACEMENT THERAPY; RETROSPECTIVE STUDY; SYSTEMATIC REVIEW; TREATMENT OUTCOME;

GLOMERULONEPHRITIS, IGA; HUMANS; IMMUNOSUPPRESSIVE AGENTS; META-ANALYSIS AS TOPIC; MYCOPHENOLIC ACID; PRODRUGS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TREATMENT OUTCOME;

EID: 38149095111     PISSN: 13205358     EISSN: 14401797     Source Type: Journal    
DOI: 10.1111/j.1440-1797.2007.00868.x     Document Type: Letter

References (7)

1. Sahin GM, Sahin S, Kantarci G, Ergin H. Mycophenolate mofetil treatment for therapy-resistant glomerulopathies. Nephrology 2007 12 : 285 8.
2. Zhu B, Chen N, Lin Y et al. Mycophenolate mofetil in induction and maintenance therapy of severe lupus nephritis: a meta-analysis of randomized controlled trials. Nephrol. Dial. Transplant. 2007 22 : 1933 42.
3. Frisch G, Lin J, Rosenstock J et al. Mycophenolate mofetil (MMF) vs placebo in patients with moderately advanced IgA nephropathy: a double-blind randomized controlled trial. Nephrol. Dial. Transplant. 2005 20 : 2139 45.
4. Tang S, Leung JC, Chan LY et al. Mycophenolate mofetil alleviates persistent proteinuria in IgA nephropathy. Kidney Int. 2005 68 : 802 12.
5. Maes BD, Oyen R, Claes K et al. Mycophenolate mofetil in IgA nephropathy: results of a 3-year prospective placebo-controlled randomized study. Kidney Int. 2004 65 : 1842 9.
6. Chen X, Chen P, Cai G et al. A randomized control trial of mycophenolate mofeil treatment in severe IgA nephropathy. Zhonghua Yi Xue Za Zhi 2002 82 : 796 801.
7. Hogg RJ, Wyatt RJ, Scientific Planning Committee of the North American IgA Nephropathy Study. A randomized controlled trial of mycophenolate mofetil in patients with IgA nephropathy [ISRCTN62574616]. BMC Nephrol. 2004 5 : 3.